title: Progesterone inhibits 20alpha-hydroxysteroid dehydrogenase expression in the rat corpus luteum through the glucocorticoid receptor.
abstract: In this study, we investigated whether progesterone exerts an intraluteal action despite the lack of progesterone receptors (PR) in the rat corpus luteum and whether progesterone acts through the glucocorticoid receptor (GR) to enhance its own levels by down-regulating the expression of 20alpha-hydroxysteroid dehydrogenase (20alpha-HSD). We first established that the corpus luteum constitutively expresses the GR throughout pregnancy and after parturition. We also generated a temperature sensitive SV-40 transformed luteal cell line (GG-CL) that expresses the GR and 20alpha-HSD but lacks the PR. Treatment with different doses of either progesterone or dexamethasone caused a dose-related decrease in 20alpha-HSD mRNA in both cultured corpora lutea and in the luteal cell line. RU486, a PR/GR antagonist, completely blocked both the progesterone and the dexamethasone mediated inhibition of 20alpha-HSD expression in GG-CL cells. In summary, this report provides the first evidence that despite the absence of the PR in the rat corpus luteum, progesterone can act through the GR to down-regulate the expression of 20alpha-HSD, an enzyme that catabolizes progesterone and reduces progesterone secretion by the corpus luteum.
authors.affiliation: Department of Physiology and Biophysics, University of Illinois at Chicago, 60612-7342, USA.
authors.forename: N
authors.initials: N
authors.lastname: Sugino
authors.forename: C M
authors.initials: CM
authors.lastname: Telleria
authors.forename: G
authors.initials: G
authors.lastname: Gibori
mesh_terms: D015089:20-Hydroxysteroid Dehydrogenases / Q000032:analysis* / Q000235:genetics*; D000818:Animals; D001483:Base Sequence; D002461:Cell Line, Transformed; D003338:Corpus Luteum / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D004247:DNA / Q000032:analysis / Q000737:chemistry / Q000235:genetics; D003907:Dexamethasone / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation / Q000187:drug effects; D005260:Female; D005434:Flow Cytometry; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D015735:Mifepristone / Q000494:pharmacology; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D011374:Progesterone / Q000378:metabolism / Q000494:pharmacology*; D012333:RNA, Messenger / Q000032:analysis / Q000737:chemistry / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D011965:Receptors, Glucocorticoid / Q000037:antagonists & inhibitors / Q000187:drug effects* / Q000502:physiology; D011980:Receptors, Progesterone / Q000032:analysis / Q000037:antagonists & inhibitors / Q000187:drug effects
chemical_list: D012333:RNA, Messenger; D011965:Receptors, Glucocorticoid; D011980:Receptors, Progesterone; D015735:Mifepristone; D011374:Progesterone; D003907:Dexamethasone; D004247:DNA; D015089:20-Hydroxysteroid Dehydrogenases